Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 728 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 728 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $58,458.40. Following the completion of the sale, the director owned 10,799 shares of the company’s stock, valued at $867,159.70. This trade represents a 6.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Docusign Stock Performance

Shares of NASDAQ:DOCU opened at $84.52 on Thursday. The stock has a fifty day moving average of $75.99 and a 200-day moving average of $79.26. The company has a market capitalization of $17.00 billion, a PE ratio of 63.55, a price-to-earnings-growth ratio of 4.28 and a beta of 1.02. Docusign Inc. has a one year low of $55.14 and a one year high of $107.86.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. Docusign’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, research analysts forecast that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its board has authorized a share repurchase plan on Thursday, June 5th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Hedge Funds Weigh In On Docusign

A number of institutional investors and hedge funds have recently made changes to their positions in DOCU. Palogic Value Management L.P. grew its stake in Docusign by 2.2% in the 1st quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock valued at $443,000 after acquiring an additional 117 shares during the period. Wealthspire Advisors LLC increased its position in shares of Docusign by 1.9% during the 1st quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company’s stock worth $536,000 after purchasing an additional 122 shares during the last quarter. Foundry Partners LLC grew its position in Docusign by 1.5% in the 1st quarter. Foundry Partners LLC now owns 8,491 shares of the company’s stock valued at $691,000 after acquiring an additional 125 shares in the last quarter. Bessemer Group Inc. grew its position in Docusign by 27.5% in the 1st quarter. Bessemer Group Inc. now owns 602 shares of the company’s stock valued at $49,000 after acquiring an additional 130 shares in the last quarter. Finally, Centaurus Financial Inc. grew its position in Docusign by 2.6% in the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on DOCU. Morgan Stanley boosted their price objective on shares of Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. Zacks Research raised shares of Docusign from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 9th. Piper Sandler increased their price target on shares of Docusign from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, September 5th. Argus reiterated a “hold” rating on shares of Docusign in a research report on Monday, September 8th. Finally, Evercore ISI raised their price target on shares of Docusign from $90.00 to $92.00 and gave the company an “in-line” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have given a Hold rating to the stock. According to data from MarketBeat.com, Docusign has an average rating of “Hold” and a consensus target price of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.